Building the In Vivo Future: What Lilly’s Kelonia Bet Really Signals
By Amith Chordia and John Barry. Eli Lilly’s recent acquisition of Kelonia raised eyebrows, not because of what’s proven, but
By Amith Chordia and John Barry. Eli Lilly’s recent acquisition of Kelonia raised eyebrows, not because of what’s proven, but
SAI MedPartners Enhances Its Competitive Intelligence Capabilities Through the Acquisition of The Dunn Group December 3, 2025 Reading, PA SAI